Fairfax Financial Holdings’s Meridian Bioscience Inc VIVO Stock Holding History

Fairfax Financial Holdings’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-41,400	Closed	-$1.37M	–	75
2022 Q4	$1.37M	Buy	+41,400	New	+$1.33M	0.03%	42

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fairfax Financial Holdings's VIVO Position: Q1 2023 in Review

Fairfax Financial Holdings sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 41,400 shares — an estimated $1.37M sold.

Fairfax Financial Holdings first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $1.37M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Fairfax Financial Holdings reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Fairfax Financial Holdings sold 41,400 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.37M.
Fairfax Financial Holdings first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
Fairfax Financial Holdings's Meridian Bioscience Inc position peaked at $1.37M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Fairfax Financial Holdings's 13F filing for Q1 2023, filed 15 May 2023.